AU737549C - Antimitotic halo derivatives of vinca alkaloids - Google Patents

Antimitotic halo derivatives of vinca alkaloids

Info

Publication number
AU737549C
AU737549C AU73408/98A AU7340898A AU737549C AU 737549 C AU737549 C AU 737549C AU 73408/98 A AU73408/98 A AU 73408/98A AU 7340898 A AU7340898 A AU 7340898A AU 737549 C AU737549 C AU 737549C
Authority
AU
Australia
Prior art keywords
antimitotic
vinca alkaloids
halo derivatives
formula
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU73408/98A
Other languages
English (en)
Other versions
AU737549B2 (en
AU7340898A (en
Inventor
Jean-Marc Barret
Alain Duflos
Jacques Fahy
Bridget Hill
Valerie Thillaye Du Boulay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre Medicament SA
Original Assignee
Pierre Fabre Medicament SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA
Publication of AU7340898A publication Critical patent/AU7340898A/en
Publication of AU737549B2 publication Critical patent/AU737549B2/en
Application granted granted Critical
Publication of AU737549C publication Critical patent/AU737549C/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU73408/98A 1997-04-10 1998-04-10 Antimitotic halo derivatives of vinca alkaloids Expired AU737549C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9704398A FR2761990B1 (fr) 1997-04-10 1997-04-10 Derives halogenes antimitotiques d'alcaloides de vinca
FR97/04398 1997-04-10
PCT/FR1998/000730 WO1998045301A1 (fr) 1997-04-10 1998-04-10 Derives halogenes antimitotiques d'alcaloides de vinca

Publications (3)

Publication Number Publication Date
AU7340898A AU7340898A (en) 1998-10-30
AU737549B2 AU737549B2 (en) 2001-08-23
AU737549C true AU737549C (en) 2002-03-28

Family

ID=9505731

Family Applications (1)

Application Number Title Priority Date Filing Date
AU73408/98A Expired AU737549C (en) 1997-04-10 1998-04-10 Antimitotic halo derivatives of vinca alkaloids

Country Status (15)

Country Link
US (1) US6127377A (enExample)
EP (3) EP1764368B1 (enExample)
JP (3) JP4401440B2 (enExample)
AT (2) ATE473987T1 (enExample)
AU (1) AU737549C (enExample)
BR (2) BR9816177B1 (enExample)
CA (3) CA2665949C (enExample)
CY (2) CY1111476T1 (enExample)
DE (3) DE69824840T2 (enExample)
DK (2) DK0975640T3 (enExample)
ES (2) ES2222588T3 (enExample)
FR (2) FR2761990B1 (enExample)
LU (1) LU91769I2 (enExample)
PT (2) PT1764368E (enExample)
WO (1) WO1998045301A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
EP1694330A4 (en) * 2003-12-04 2009-06-24 Amr Technology Inc DERIVATIVES OF VINORELBINE
NZ547370A (en) * 2003-12-04 2010-09-30 Amr Technology Inc Vinca derivatives
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
CA2607940C (en) 2005-05-18 2009-12-15 Aegera Therapeutics Inc. Bir domain binding compounds
FR2894966B1 (fr) * 2005-12-20 2008-03-14 Pierre Fabre Medicament Sa Nouvelle forme cristalline de la vinflunine
MY159563A (en) 2006-05-16 2017-01-13 Pharmascience Inc Iap bir domain binding compounds
US20080125451A1 (en) * 2006-09-12 2008-05-29 Amr Technology, Inc. Vinorelbine derivatives
US8039453B2 (en) * 2006-09-12 2011-10-18 Albany Molecular Research, Inc. Vinca derivatives
FR2905949B1 (fr) * 2006-09-20 2008-11-21 Pierre Fabre Medicament Sa Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
FR2912406B1 (fr) 2007-02-13 2009-05-08 Pierre Fabre Medicament Sa Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
US20090076055A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched vinflunine
DE102010020994B4 (de) * 2010-01-27 2022-01-27 Interpane Entwicklungs-Und Beratungsgesellschaft Mbh Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen
NZ602368A (en) 2010-02-12 2014-10-31 Pharmascience Inc Iap bir domain binding compounds
US8940754B2 (en) 2010-02-22 2015-01-27 The Scripps Research Institute 10′-fluorinated Vinca alkaloids provide enhanced biological activity against MDR cancer cells

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988A1 (fr) * 1993-07-21 1995-01-27 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707988A1 (fr) * 1993-07-21 1995-01-27 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.

Also Published As

Publication number Publication date
ATE270297T1 (de) 2004-07-15
CA2665949C (fr) 2013-06-11
JP2009167196A (ja) 2009-07-30
AU737549B2 (en) 2001-08-23
DE69824840T2 (de) 2005-07-21
DE69824840D1 (de) 2004-08-05
EP1357125A2 (fr) 2003-10-29
JP2001518892A (ja) 2001-10-16
CA2455416A1 (fr) 1998-10-15
DE69841766D1 (de) 2010-08-26
PT1764368E (pt) 2010-09-16
JP4401440B2 (ja) 2010-01-20
FR2761990A1 (fr) 1998-10-16
US6127377A (en) 2000-10-03
BR9807944B1 (pt) 2011-02-08
CA2286560C (fr) 2009-09-08
WO1998045301A1 (fr) 1998-10-15
CY2010019I2 (el) 2012-01-25
JP4307292B2 (ja) 2009-08-05
LU91769I2 (fr) 2011-02-22
FR2761990B1 (fr) 1999-06-25
ES2222588T3 (es) 2005-02-01
PT975640E (pt) 2004-11-30
CY1111476T1 (el) 2012-01-25
BR9816177B1 (pt) 2010-08-24
CA2286560A1 (fr) 1998-10-15
EP0975640B1 (fr) 2004-06-30
DE122010000054I1 (de) 2011-05-05
FR10C0045I2 (fr) 2011-04-29
ES2347878T3 (es) 2010-11-22
EP1357125A3 (fr) 2003-11-26
DK1764368T3 (da) 2010-10-18
AU7340898A (en) 1998-10-30
EP0975640A1 (fr) 2000-02-02
EP1764368B1 (fr) 2010-07-14
CA2665949A1 (fr) 1998-10-15
CA2455416C (fr) 2010-11-02
CY2010019I1 (el) 2012-01-25
FR10C0045I1 (enExample) 2010-10-29
ATE473987T1 (de) 2010-07-15
JP2004277418A (ja) 2004-10-07
BR9807944A (pt) 2000-03-08
EP1764368A1 (fr) 2007-03-21
DK0975640T3 (da) 2004-11-01

Similar Documents

Publication Publication Date Title
FR10C0045I1 (enExample)
UA6340A1 (uk) Спосіб одержання заміщених діазабіціклоалкілхінолон карбонових кислот мостиковим зв'язком або їх фармацевтично прийнятних адитивний солей
IE873152L (en) Rebeccamycin analogs
ZA859805B (en) 6-thioxanthine derivatives
DE3376323D1 (en) Process for producing beta-carboline derivatives
AU5835190A (en) Antitumor substance be-13793c
AU669212B2 (en) Process for the purification of crude clavulanic acid
HK131993A (en) Preparation of non-racemic furo[3,4-c]pyridine derivatives
JPS57109787A (en) Pyrazoloindazole derivative
AU2847084A (en) B-carbolin-3-carboxylic acid derivatives
EP0222022A4 (en) MANUFACTURING METHOD OF BETA LACTAM COMBS.
KR850001756A (ko) 벤조디아제핀 유도체의 제조방법
AU585015B2 (en) Process for preparing 6-amino-3-hydrazinopyridazine derivatives
GR861782B (en) Method for preparing n-methyl derivatives of ergoline
AU557880B2 (en) Method for modulating the immune response with dibenzocycloheptenylidenes
JPS57192342A (en) Isoprenylamine derivative
AU576217B2 (en) Perfluoroalkyldichloroethylenes and production of perfluoroalkanecarboxylic acids
JPS5718680A (en) Indole derivative
JPS54151985A (en) Preparation of aminocarbostyril derivative
HUT41393A (en) Process for producing pyridazine derivatives
Ettler et al. Ergot oil- a new substrate for fermentation industry.
JPS51113890A (en) Method for preparing novel cephalosporins
JPS54138600A (en) Benzo-azabicyclo3,3,1-nonane derivative
JPS5569539A (en) Bicyclo 3,3,0 octane derivative and its preparation
JPS57142987A (en) N-acyl c-15003pnd and its preparation

Legal Events

Date Code Title Description
DA2 Applications for amendment section 104

Free format text: THE NATURE OF THE PROPOSED AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 20010810

FGA Letters patent sealed or granted (standard patent)
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS WAS NOTIFIED IN THE OFFICIAL JOURNAL DATED 20010920